| Reaction Details |
|---|
 | Report a problem with these data |
| Target | Tyrosine-protein kinase JAK2 [808-1132] |
|---|
| Ligand | BDBM103727 |
|---|
| Substrate/Competitor | n/a |
|---|
| Meas. Tech. | Biochemical Activity Assay |
|---|
| IC50 | 460±n/a nM |
|---|
| Citation |  Bursulaya, B; Fisch, A; Lajiness, JP; Machauer, R; Malekar, S; Petrassi, HM; Ramazani, F; Remond, A; Ullrich, T; Usselmann, P; Vangrevelinghe, E Aza-indazole compounds for use in tendon and/or ligament injuries US Patent US11203595 Publication Date 12/21/2021 |
|---|
| More Info.: | Get all data from this article, Assay Method |
|---|
| |
| Tyrosine-protein kinase JAK2 [808-1132] |
|---|
| Name: | Tyrosine-protein kinase JAK2 [808-1132] |
|---|
| Synonyms: | JAK2 | JAK2 (aa 808-1132) | JAK2_HUMAN | Tyrosine-protein kinase JAK2 JH1 (808-1132) |
|---|
| Type: | Protein |
|---|
| Mol. Mass.: | 39171.39 |
|---|
| Organism: | Homo sapiens (Human) |
|---|
| Description: | O60674[808-1132] |
|---|
| Residue: | 335 |
|---|
| Sequence: | FRAIIRDLNSLFTPDYELLTENDMLPNMRIGALGFSGAFEDRDPTQFEERHLKFLQQLGK
GNFGSVEMCRYDPLQDNTGEVVAVKKLQHSTEEHLRDFEREIEILKSLQHDNIVKYKGVC
YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLGTKRYIHRDL
ATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDV
WSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRPDGCPDE
IYMIMTECWNNNVNQRPSFRDLALRVDQIRDNMAG
|
|
|
|---|
| BDBM103727 |
|---|
| n/a |
|---|
| Name | BDBM103727 |
|---|
| Synonyms: | US10112907, Example 00033 | US10206907, Compound 200 | US10708263, Compound 1 | US10766894, Compound TABLE 1.18 | US10919890, Compound 1 | US10961228, Example Filgotinib | US11000528, Cpd # 1 | US11203595, TABLE 1.18 | US11279699, Compound Filgotinib | US8563545, 1 |
|---|
| Type | Small organic molecule |
|---|
| Emp. Form. | C21H23N5O3S |
|---|
| Mol. Mass. | 425.504 |
|---|
| SMILES | O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1 |
|---|
| Structure | 
|
|---|
Search and Browse
